SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-006646
Filing Date
2019-02-12
Accepted
2019-02-12 16:15:21
Documents
1
Period of Report
2019-02-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv513043_8-k.htm 8-K 14803
  Complete submission text file 0001144204-19-006646.txt   16141
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Filer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35112 | Film No.: 19590952
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1